PERIPARTAL KARDIOMIOPATIYADA OG‘IR YURAK ETISHMOVCHILIGINING ZAMONAVIY INTENSIV TERAPIYA STRATEGIYALARI
Keywords:
PKMPdagi OYEning zamonaviy intensiv terapiya yondashuvlarini epidemiologik ma’lumotlar, patofiziologik mexanizmlar va klinik tavsiyalar nuqtai nazaridan tahlil qilishdan iborat.Abstract
Peripartal kardiomiopatiya (PKMP) — homiladorlikning so‘nggi
oyida yoki tug‘ruqdan keyingi 5 oy ichida ilgari yurak kasalliklari bo‘lmagan ayollarda
og‘ir yurak etishmovchiligi (OYE) rivojlanishi bilan kechadigan kam uchraydigan
kasallik bo‘lib, ona o‘limi darajasi yuqori (6 oy ichida 6–10%). PKMPdagi OYEning
intensiv terapiyasi kompleks yondashuvni talab qiladi: dori-darmon bilan davolash,
gemodinamikani doimiy monitoring qilish va og‘ir holatlarda qon aylanishini mexanik
qo‘llab-quvvatlash usullari qo‘llaniladi. Ushbu maqola PKMPdagi OYEning
epidemiologiyasi, patofiziologiyasi, intensiv terapiya strategiyalari va prognozini
zamonaviy ma’lumotlar asosida umumlashtiradi, statistik ko‘rsatkichlar va klinik
tavsiyalarga alohida e’tibor qaratilgan.
References
1. Mebazaa A, Tolppanen H, Mueller C, Lassus J, di Somma S, a Baksyte G, et al. Acute heart failure and cardiogenic
2016; 42(2): practical 147–63. guidance. doi: Intensive 10.1007/s00134-
015-4041-5. 2. Sheppard R, Rajagopalan N, Safirstein J, Briller J. An update on treatments and outcomes in peripartum cardiomyopathy. Future Cardiol. 2014. 10.2217/fca.14.23 3. Sliwa K, and Damasceno etiology Circulation. 10(3), A, of Mayosi cardiomyopathy 2005;112:3577–83.
CIRCULATIONAHA.105.542894. 4. Sliwa
K,
A,
Pieske
knowledge
therapy
Hilfiker-Kleiner
B,
on
of
Buchmann
aetiology,
peripartum
D,
E,
diagnosis,
435–47.
BM.
doi:
Petrie
et
al.
in
MC,
Current
management,
cardiomyopathy:
statement
Society
from
of
Heart
Cardiology
Failure
Working
Association
Group
of
on
doi:
Epidemiology
Africa.
10.1161/
Mebazaa
state
a
of
and
position
European
peripartum
